{
    "Trade/Device Name(s)": [
        "Lia Pregnancy Test"
    ],
    "Submitter Information": "LIA Diagnostics, Inc.",
    "510(k) Number": "K171136",
    "Predicate Device Reference 510(k) Number(s)": [
        "K974159"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCX"
    ],
    "Summary Letter Date": "July 27, 2018",
    "Summary Letter Received Date": "October 23, 2017",
    "Submission Date": "November 17, 2017",
    "Regulation Number(s)": [
        "21 CFR 862.1155"
    ],
    "Regulation Name(s)": [
        "Human chorionic gonadotropin (HCG) test system"
    ],
    "Analyte Class(es)": [
        "endocrine"
    ],
    "Analyte(s)": [
        "Human Chorionic Gonadotropin (hCG)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Lateral flow chromatographic immunoassay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Kit",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Lia Pregnancy Test, an over-the-counter lateral flow immunochromatographic assay for qualitative detection of hCG in urine",
    "Indications for Use Summary": "Intended for non-professional, over-the-counter use for the qualitative identification of elevated levels of human chorionic gonadotropin (hCG) in urine to aid in the determination of pregnancy",
    "fda_folder": "Clinical Chemistry"
}